Skip to main content
SpringerLink
Log in

Antianämika

  • Chapter
Arzneiverordnungs-Report 2015

Zusammenfassung

Der größte Teil der Verordnungen von Antianämika entfällt weiterhin auf Eisenpräparate mit einem steigenden Anteil von parenteralen Präparaten und Folsäurekombinationen. Danach folgen Epoetinpräparate und Folsäure mit jeweils deutlich geringeren Verordnungsvolumina.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Albaramki J, Hodson EM, Craig JC, Webster AC (2012): Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Cochrane Database Syst Rev. 2012 Jan 18; 1: CD00785–7

    Google Scholar 

  • Auerbach M, Ballard H (2010): Clinical use of intravenous iron: administration, efficacy, and safety. Hematology Am Soc Hematol Educ Program: 338–347

    Google Scholar 

  • Baker WF, Bick RL (1999): Treatment of hereditary and acquired thrombophilic disorders. Semin Thromb Hemost 25: 387–406

    Article  CAS  PubMed  Google Scholar 

  • Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke M, Weingart O, Kluge S, Piper M, Rades D, Steensma DP, Djulbegovic B, Fey MF, Ray-Coquard I, Machtay M, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A (2009): Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet 373: 1532–1542

    Article  CAS  PubMed  Google Scholar 

  • Camaschella C (2015): Iron-deficiency anemia. N Engl J Med 372:1832–1843

    Article  PubMed  Google Scholar 

  • Curran MP, McCormack PL (2008): Methoxy polyethylene glycol-epeoetin beta: a review of ist use in the management of anaemia associated with chronic kidney disease. Drugs 68: 1139–1156

    Article  CAS  PubMed  Google Scholar 

  • Drüeke TB, Locatelli F, Clyne N, Eckardt KU, Mcdougall IC et al. (2006): Normalization of hemo- globin level in patients with chronic kidney disease and anemia. N Engl J Med 355: 2071208–4

    Article  Google Scholar 

  • Dührsen U (2002): Gibt es Indikationen für Erythropoetin in der Onkologie? Dtsch Ärztebl 99: A3470–A3475

    Google Scholar 

  • European Medicines Agency (2008): Questions and answers on epoetins and risk of tumor growth and blood clots in the vein. Internet: www.ema.europa.eu/docs/en_GB/docu- ment_library/Medicine_QA/2009/11/WC500015145.pdf Fishbane S (2003): Safety in iron management. Am J Kidney Dis 41 (5 Suppl): 18–26

    Google Scholar 

  • Fishbane S, Mittal SK, Maesaka JK (1999): Beneficial effects of iron therapy in renal failure patients on hemodialysis. Kidney Int 55: 67–70

    Article  Google Scholar 

  • Food and Drug Administration (2007): Information for Healthcare Professionals November 8, 2007. Erythropoesis stimulating agents (ESA). Internet: www.fda.gov/cder/drug/InfoSheets/HCP/RHE200711HCP.htm

  • Hermann W, Obeid R (2011): Die obligatorische Folsäurefortifikation von Nahrungsmitteln. Ein in Deutschland kontrovers diskutiertes Thema. Dtsch Ärztebl 108: 249–254

    Google Scholar 

  • Hörl WH, Vanrenterghem Y (2005): Optimal treatment of renal anaemia (OPTA): improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intra- venous epoetin. NephrolDialTransplant 20, Suppl.3: iii25–32

    Google Scholar 

  • Ibbotson T, Goa KL (2001): Darbepoetin alfa. Drugs 61: 2097–2104

    Article  CAS  PubMed  Google Scholar 

  • Kaufman JS, Reda DJ, Fye CL, Goldfarb DS, Henderson WG et al. (1998): Subcutaneous com- pared with intravenous epoetin in patients receiving hemodialysis. N Engl J Med 339: 578–583

    Article  CAS  PubMed  Google Scholar 

  • Koletzko B, Pietrzik K (2004): Gesundheitliche Bedeutung der Folsäurezufuhr. Dtsch Ärztebl 101:A 1670–1681

    Google Scholar 

  • Lee TW, Kolber MR, Fedorak RN, van Zanten SV (2012):Iron replacement therapy in inflammato- ry bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis. J Crohns Colitis 6: 267–275

    Article  PubMed  Google Scholar 

  • Marsh WA, Rascati KL (1999): Meta-analyses of the effectiveness of erythropoetin for end-stage renal disease and cancer. Clin Ther 21: 1443–1455

    Article  CAS  PubMed  Google Scholar 

  • Martf-Carvajal AJ, Sola I, Lathyris (2015): Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2015 Jan 15;1:CD006612 Meerpohl JJ, Schell LK, Rücker G, Motschall E, Fleeman N, Niemeyer CM, Bassler D (2014): Deferasirox for managing transfusional iron overload in people with sickle cell disease. Cochrane Database Syst Rev. 2014 May 27; 5: CD007477

    Google Scholar 

  • Nielsen P, Kongi R, Buggisch P, Fischer R (2005): Bioavailability of oral iron drugs as judged by a 59Fe-whole-body counting technique in patients with iron deficiency anaemia. Therapeu- tic efficacy of iron(II)-glycine sulfate. Arzneimittelforschung 55: 376–381

    CAS  PubMed  Google Scholar 

  • Röhrig G, Doehner W, Schaefer RM, Schulz RJ (2012): Anämie und Eisenmangel in der Geriatrie.

    Google Scholar 

  • Prävalenz, Diagnostik und neue Therapieoptionen. Z Gerontol Geriatr 45: 191–196

    Google Scholar 

  • Santiago P (2012): Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overview. ScientificWorldJournal 2012: 84682–4. doi: 10.1100/2012/846824.

    Article  Google Scholar 

  • Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S et al. (2006): Correction of anemia with epoe- tin alfa in chronic kidney disease. N Engl J Med 355: 2085–2098

    Article  CAS  PubMed  Google Scholar 

  • Steffensen GK, Stergaard O (2011): Administration of the same dose of epoetin-beta intrave- nously subcutaneously to patients with renal anaemia. Scand J Urol Nephrol 45: 461–469

    Article  CAS  PubMed  Google Scholar 

  • Thomas L, Thomas C, Heimpel H (2005): Neue Parameter zur Diagnostik von Eisenmangelzuständen. Dtsch Ärztebl 102: A 580–586

    Google Scholar 

  • Tonia T, Mettler A, Robert N, Schwarzer G, Seidenfeld J, Weingart O, Hyde C, Engert A, Bohlius J (2012): Erythropoietin or darbepoetin for patients with cancer. Cochrane Database Syst Rev. 2012 Dec 12; 12: CD00340–7

    Google Scholar 

  • Wald NJ (2004): Folic acid and the prevention of neural-tube defects. N Engl J Med 350: 101–103

    Article  CAS  PubMed  Google Scholar 

  • Weiss LG, Clyne N, Divino Fihlho J, Frisenette-Fich C, Kurkus J, Svensson B (2000): The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin ß: results from a randomized controlled multicentre trial. Swedish Study Group. Nephrol Dial Trans- plant 15: 2014-2019 8

    Google Scholar 

Download references

Authors
  1. Klaus Mengel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2015 Springer-Verlag Berlin Heidelberg

    About this chapter

    Cite this chapter

    Mengel, K. (2015). Antianämika. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2015. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-47186-9_7

    Download citation

    • DOI: https://doi.org/10.1007/978-3-662-47186-9_7

    • Publisher Name: Springer, Berlin, Heidelberg

    • Print ISBN: 978-3-662-47185-2

    • Online ISBN: 978-3-662-47186-9

    • eBook Packages: Medicine (German Language)

    Publish with us

    Policies and ethics

    Search

    Navigation